Role of Estrogen in Hepatocellular Carcinoma: is Inflammation the Key?

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2014 Apr 9

PMID 24708807

Citations 69

Authors

Liang Shi

Yili Feng

Hui Lin

Rui Ma

Xiujun Cai

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and accounts for the third-leading cause of cancer-related deaths. Over the past decades, advances have been made in the field of surgery, but effective treatment of HCC is lacking. Due to a marked male predominance in morbidity and mortality in HCC patients, it has long been considered that sex hormones play a role in HCC development. Recently estrogen has been proven to exert protective effects against HCC through IL-6 restrictions, STAT3 inactivation and tumour-associated macrophage inhibition. While IL-6-dependent STAT3 activation is considered a key event in inflammation-induced liver cancer, the anti-inflammation effect of estrogen is well documented. The roles of the estrogen receptor and aromatase and interactions between microRNAs and estrogen in HCC have been investigated. In this review, we present a novel model to elucidate the mechanism of estrogen-mediated inhibition of HCC development through an anti-inflammation effect and provide new insights into the roles of estrogen in liver disease.

Citing Articles

Loss of STAT3 in osteoblasts has detrimental and sexually dimorphic effects on skeletal development.

Davidson R, Corry K, Orlofsky A, Li P, Russell C, Zhang A PLoS One. 2024; 19(12):e0315078.

PMID: 39689092 PMC: 11651548. DOI: 10.1371/journal.pone.0315078.

An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules.

Xiao Z, Yang F, Liu Z, Chen X, Ma S, Li H Therap Adv Gastroenterol. 2024; 17:17562848241293019.

PMID: 39493259 PMC: 11528798. DOI: 10.1177/17562848241293019.

Tamoxifen for adults with hepatocellular carcinoma.

Naing C, Ni H, Aung H Cochrane Database Syst Rev. 2024; 8():CD014869.

PMID: 39132750 PMC: 11318082. DOI: 10.1002/14651858.CD014869.pub2.

Supportive care of female hormones in brain health: what and how?.

Zhu A, Song S, Pei L, Huang Y Front Pharmacol. 2024; 15:1403969.

PMID: 39114348 PMC: 11303335. DOI: 10.3389/fphar.2024.1403969.

Gene therapy for people with hepatocellular carcinoma.

Naing C, Ni H, Aung H, Htet N, Nikolova D Cochrane Database Syst Rev. 2024; 6:CD013731.

PMID: 38837373 PMC: 11152182. DOI: 10.1002/14651858.CD013731.pub2.

References

Fan Y, Mao R, Yang J . NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013; 4(3):176-85. PMC: 4875500. DOI: 10.1007/s13238-013-2084-3. View

Di Maio M, De Maio E, Morabito A, DAniello R, De Feo G, Gallo C . Hormonal treatment of human hepatocellular carcinoma. Ann N Y Acad Sci. 2007; 1089:252-61. DOI: 10.1196/annals.1386.007. View

Rodriguez E, Lopez R, Paez A, Masso F, Montano L . 17Beta-estradiol inhibits the adhesion of leukocytes in TNF-alpha stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci. 2002; 71(18):2181-93. DOI: 10.1016/s0024-3205(02)01999-9. View

Gilmore W, Weiner L, Correale J . Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol. 1997; 158(1):446-51. View

Yu X, Gupta A, Wang Y, Suzuki K, Mirosevich J, Orgebin-Crist M . Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Ann N Y Acad Sci. 2006; 1061:77-93. DOI: 10.1196/annals.1336.009. View

Shimizu I . Impact of oestrogens on the progression of liver disease. Liver Int. 2003; 23(1):63-9. DOI: 10.1034/j.1600-0676.2003.00811.x. View

Farinati F, de Maria N, Marafin C, Fagiuoli S, Della Libera G, Naccarato R . Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor?. Eur J Gastroenterol Hepatol. 1995; 7(2):145-50. View

FECHNER R . Benign hepatic lesions and orally administered contraceptives. A report of seven cases and a critical analysis of the literature. Hum Pathol. 1977; 8(3):255-68. DOI: 10.1016/s0046-8177(77)80022-1. View

Berasain C, Perugorria M, Latasa M, Castillo J, Goni S, Santamaria M . The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood). 2009; 234(7):713-25. DOI: 10.3181/0901-MR-12. View

10.

Ma W, Hsu C, Yeh C, Wu M, Huang C, Jeng L . Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology. 2012; 56(1):176-85. PMC: 3673306. DOI: 10.1002/hep.25644. View

11.

Yu M, Chang H, Chang S, Liaw Y, Lin S, Liu C . Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology. 2003; 38(6):1393-400. DOI: 10.1016/j.hep.2003.09.041. View

12.

Calvisi D . Dr. Jekyll and Mr. Hyde: a paradoxical oncogenic and tumor suppressive role of signal transducer and activator of transcription 3 in liver cancer. Hepatology. 2011; 54(1):9-12. DOI: 10.1002/hep.24435. View

13.

Sceusi E, Loose D, Wray C . Clinical implications of DNA methylation in hepatocellular carcinoma. HPB (Oxford). 2011; 13(6):369-76. PMC: 3103092. DOI: 10.1111/j.1477-2574.2011.00303.x. View

14.

De Maria N, Manno M, Villa E . Sex hormones and liver cancer. Mol Cell Endocrinol. 2002; 193(1-2):59-63. DOI: 10.1016/s0303-7207(02)00096-5. View

15.

Kanda N, Tamaki K . Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999; 103(2 Pt 1):282-8. DOI: 10.1016/s0091-6749(99)70503-8. View

16.

Barone I, Brusco L, Fuqua S . Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res. 2010; 16(10):2702-8. PMC: 4477803. DOI: 10.1158/1078-0432.CCR-09-1753. View

17.

Smolev J, Coffey D, Scott W . Experimental models for the study of prostatic adenocarcinoma. J Urol. 1977; 118(1 Pt 2):216-20. DOI: 10.1016/s0022-5347(17)57949-5. View

18.

Oursler M, Cortese C, Keeting P, Anderson M, Bonde S, Riggs B . Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology. 1991; 129(6):3313-20. DOI: 10.1210/endo-129-6-3313. View

19.

Gomaa A, Khan S, Toledano M, Waked I, Taylor-Robinson S . Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008; 14(27):4300-8. PMC: 2731180. DOI: 10.3748/wjg.14.4300. View

20.

Strom A, Hartman J, Foster J, Kietz S, Wimalasena J, Gustafsson J . Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A. 2004; 101(6):1566-71. PMC: 341775. DOI: 10.1073/pnas.0308319100. View